Hurone AI is accelerating global access to precision cancer care and transforming global oncology through the power of artificial intelligence.
We empower oncologists in care delivery to improve patient outcomes, and provide pharma companies and CROs with real-world data and AI solutions to support clinical trials in order to make cancer care accessible to everyone, everywhere.
We have partnered with 3 major centers in Nigeria, Kenya and Rwanda who will use our solutions to serve their 10,000+ patients.
Gukiza, our software, reduced off-duty oncology calls by approximately 60% for cancer care teams in our partner sites.
Our software is optimized, in strict compliance with data privacy laws, to gather anonymized data from thousands of underrepresented patients to support the clinical trial process.
Majority of our patients fully engage with our software and find it helpful in saving time and getting easier access to treatment.
Oncologists saved more than 75% of the time traditionally required to handle specific care responsibilities by using our AI solutions.
The global oncology software market is projected to reach $11 billion by 2025, growing at a CAGR of 7.8% from 2022 to 2027.
AI SUPPORT
REMOTE CARE
CARE AUTOMATION
PHASE III trial SUPPORT
DATA DIVERSITY
PATIENT RECRUITMENT
